Age: 38.0
Sex: F
Vaccine: HPV4
Symptoms: Blood alkaline phosphatase increased, Blood iron decreased, Fatigue, Headache, Insomnia
Clinical narrative: chronic fatigue syndrome/chronic fatigue/insomnia/headaches/exhausted all the time; low iron levels; elevated alkaline phosphatase levels; autonomic injuries; neurological injuries; autoimmune dysfunctions/autoimmune injuries/; Information has been received from a lawyer regarding a case in litigation and refers to a female adult patient (pt). The pt's concurrent conditions, medical history and concomitant therapies were not provided. On unknown dates, all reported as when the patient was 38 years old, she was vaccinated with the first and second  dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) intramuscular injection (exact dose, lot #, expiration date, route of administration and anatomical location were not provided for any of administered doses) for prophylaxis (reported as "touted as a safe and effective vaccine for preventing cervical cancer"), as recommended by the pt's physician and consented by the pt. On unknown dates, she experienced serious and debilitating injuries, including but not limited to autonomic, autoimmune, and neurological injuries and resulting sequalae as a result of vaccination. On an unknown date, reported as after the second human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) vaccination, the pt began to feel exhausted all the time. The physician ran tests and her iron levels had declined from previous routine blood tests she had received. As the months progressed, so did the pt's symptoms. She was seen by multiple physicians and specialists for her complaints which included chronic fatigue, low iron levels, elevated alkaline phosphatase levels, insomnia, and headaches. The pt did not know and had no reason to know that her symptoms she was experiencing were caused by the quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) vaccine, as no information to the contrary was given to her by her medical providers. It was not until the spring of 2023 that pt began to suspect that the quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) was the cause of her symptoms and injuries. As a result of her post-quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) symptoms, the pt was unable to engage in activities that a normal young person would enjoy and her ability to function in her daily life was severely impaired. Based upon her chronic and severe post-quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) symptoms, the pt was diagnosed with various medical conditions, including but not limited to chronic fatigue syndrome. She contended that her quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) injections caused her to develop serious and debilitating autoimmune injuries, including but not limited to chronic fatigue syndrome, as well as a constellation of adverse symptoms, complications, injuries, and other adverse events, many of which were alleged herein and all of which were caused by quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) or otherwise linked to her quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) -induced autoimmune disorder. As a proximate result of the suspect vaccination, she suffered and continued to suffer severe and permanent physical injuries, and associated symptomology and suffered severe and permanent emotional injuries, including pain and suffering. The pt also had a substantial fear of suffering additional and ongoing harms, including but not limited to then being at an increased risk of cancer, and future symptoms and harms associated with her injuries caused by quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL). As a direct and proximate result of her quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL)-induced injuries, the pt suffered and continued to suffer economic losses, including considerable financial expenses for medical care and treatment, and diminished income capacity, and she would continue to incur these losses and expenses in the future. The outcome of the events was considered to be not recovered. The reporter considered all the events to be related to human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL).  Upon internal review, the event of autoimmune disorder was determined to be medically significant. The reporter considered all events to be disabling.